D49- neoplasms
steroid free CINV prophylaxis for moderately emetogenic chemotherapy in children
Who can joinChildren and adults
Age5–18 years
Kind of studyStudy of how care is given
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 21 Jul 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Dr RML Hospital and ABVIMSNew Delhi, DelhiDirections ↗
Registry summary (technical)
Fosaprepitant vs dexamethasone for prevention of CINV when given with ondansetron for moderately emetogenic chemotherapy drugs in children: a randomized control trial - NIL
Sponsor: NIL
CTRI/2025/06/089562 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 21 Jul 2025 · read by us 5 Nov 2026